WeVote
Log In

Bill

Bill

H 2503

An Act to reduce the risks associated with allergic reactions

194th Legislature (2025-2026) Introduced by Patrick Kearney and 1 co-sponsor

Massachusetts bill to reduce allergic reaction risks through unspecified mechanisms; accompanied by revised draft after committee hearing, current provisions unclear.

Accompanied a new draft, see H4607
0
WeVote Research Nonpartisan
Bill Summary · H 2503

Legislative bill overview

H 2503 is a Massachusetts bill designed to mitigate risks associated with allergic reactions, though the specific mechanisms are not detailed in the provided legislative history. The bill has undergone committee review and was accompanied by a revised draft (H4607) in October 2025, indicating substantive amendments during the legislative process.

Why is this important

Allergic reactions range from minor irritations to life-threatening anaphylaxis, affecting millions of Americans annually. Legislation addressing allergic reaction risks could impact public health infrastructure, emergency response protocols, workplace safety standards, or access to medications like epinephrine auto-injectors, depending on the bill's actual provisions.

Potential points of contention

  • Scope of mandate: Whether requirements apply broadly (schools, workplaces, public facilities) or narrowly, affecting implementation costs and compliance burden
  • Epinephrine access and liability: Questions about auto-injector availability, standing orders, training requirements, and liability protections for lay responders
  • Cost allocation: Whether expenses for equipment, training, or medication fall on state, local governments, private entities, or individuals

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.